Showing posts with label Cameron. Show all posts
Showing posts with label Cameron. Show all posts

Tuesday, May 5, 2015

The Spirit of John Johnson Alive and Well at the 2015 Dana Point Grand Prix of Cycling

Karl Menzies
Wins the 2015
Dana Point Grand Prix
Dana Point, CA. The Men’s Pro race at the Dana Point Grand Prix of Cycling this weekend exemplified what the John Johnson Family is all about – celebrating life, rewarding risks, never giving up, and going for the gusto.

John Johnson is well known on these pages. John passed away from mesothelioma in 2012. His family had every reason to be bitter. John was misdiagnosed by the VA. When he was diagnosed, an inexperienced VA surgeon attempted to operate on the tumor but aborted.

John finally found Dr. Robert Cameron, who performed a grueling 11 hour operation. But it would prove to be too late to save John from his unrelenting disease.

Wanting justice, John pursued a lawsuit against the companies who poisoned him with asbestos. His health was declining. But John knew that if he did not complete his testimony, the defendants would win and his family would be stuck with the ever-increasing bill for his illness.

One tough Marine, John hung on and preserved the record for his family so the case would live on. He passed away shortly after completing this final mission.

Michael Johnson Family
The Johnsons prevailed in their lawsuit, thanks to John’s warrior spirit and love of family. Thereafter, the Johnson family embraced John’s warrior spirit and has fought to prevent their tragedy from smacking down other families.

The Johnsons lobbied for a change in California law to make it less burdensome for ill plaintiffs to enforce their legal rights. They prevailed. They then lobbied to create a Mesothelioma Center of Excellence at the VA hospital in West Los Angeles, headed by Dr. Cameron. Again, they prevailed.

The Johnson family stands for hope, for life, and for winning, against impossible odds. For the past three years, they have been the lead sponsor of the Dana Point Grand Prix Pro Men’s race. Son Michael Johnson is a world class athlete, and he’s been using cycling as a vehicle to get the message of hope out for mesothelioma patients.

The racers heard the message. They went from the gun, all out, never looking back, not making excuses, and charged hard like it was their last race ever. A breakaway of four formed early and they held off the charging peloton at the line.

Roger Worthington, Mary and Terry
Latham and John Caron
Karl Menzies of United Health Care, a tough, savvy and muscular veteran pro hailing from Tasmania, took the victory. He was followed by youngsters Tyler Magner (Hincapie Racing), from Georgia, and Canadian Ryan Aitcheson of Team Astellas.

It was especially gratifying to have on hand another mesothelioma warrior, Terry Latham, and his lovely wife Mary. Terry, now 74 years old, was operated on by Dr. Cameron in June of 2010. Having recently celebrated his fifth year as a survivor, Terry continues to love life and go for the gusto!

Well done bike racers! Kudos to the City of Dana Point for hosting a world class event! Thank you John Johnson Family! And may the spirit keep moving you Terry and Mary Latham!

Cheers

Roger Worthington
5/5/15

Future Pro Racer

Latest Lung-Sparing Therapies, Patient Resources and “Hollywood Ending” at Pacific Meso Center’s 5th International Symposium

Dr. Robert Cameron
The Pacific Meso Center, in conjunction with The Office of Continuing Medical Education of the David Geffen School of Medicine at UCLA, held the 5th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma on May 2nd, 2015 in Santa Monica, California. The Worthington & Caron Law Firm was proud to again be the platinum sponsor of this unique medical seminar focusing on rational treatment options for patients with pleural mesothelioma.

As in years past, the course organizer and chair of the symposium was thoracic surgeon and pleural mesothelioma specialist, Dr. Robert Cameron. An ardent supporter of rational lung-sparing treatments for pleural mesothelioma, and innovator of the pleurectomy/decortication (“PD”) surgical procedure, Dr. Cameron is the founder and director of the Comprehensive Mesothelioma Program at both the UCLA Medical Center and the West Los Angeles Veterans’ Administration Medical Center.

International Panel of Specialists Discuss Latest Treatment Developments

Dr. Walter Weder
Dr. Cameron started the program with a presentation regarding the pros and cons of extending lung-sparing surgery to include the diaphragm and pericardium. Reviewing relevant study data along with his experience treating patients at UCLA and the West Los Angeles VA, Dr. Cameron concluded that it is preferable to limit the procedure to where the tumor is already present. Resection of the diaphragm and pericardium poses a risk of spreading tumor cells distantly to the abdomen and contralateral pleura and is not necessary in most patients.

In a second presentation, Dr. Cameron addressed the potential role of vaccines as an immunotherapy agent in the treatment of malignant pleural mesothelioma. He explained how vaccines can be used to overcome the immunosuppressive microenvironment of tumor cells. He sees a potential for using vaccines before, during and/or after lung- sparing surgery for pleural mesothelioma.

Dr. Walter Weder, Head of the Division of Thoracic Surgery at the University of Zurich Hospital in Switzerland, gave a presentation on his experience in transitioning from Extra-Pleural Pneumonectomy (“EPP”) to lung-sparing PD as the preferred surgical treatment for pleural mesothelioma. He also addressed a new study at the University of Zurich exploring the efficacy of a strategy to improve local control after surgery. The study, which is in its very early stages, involves spraying a mixture of Cisplatin and fibrin intraoperatively to the tumor site.

Dr. Percy Lee
Dr. Marc de Perrot, Associate Professor of Surgery at the University of Toronto, addressed the present and future use of IMRT radiation therapy before surgery. He addressed a recent study showing encouraging results for patients with epithelial mesothelioma who received one week of hemithoracic IMRT before surgery. Dr. Perrot suggested that in future studies, the protocol should be refined to include an immunotherapy agent.

Three separate presentations regarding topics relating to adjuvant radiation therapies were presented by Dr. Percy Lee, Chief of Thoracic Radiation Oncology and member of the Comprehensive Mesothelioma Program at UCLA Medical Center, Dr. Peter Chen, Radiation Oncologist at Hoag Family Cancer Institute, and Dr. Shilpen Patel, Associate Professor at the University of Washington Medical Center. The presentations revealed that recent advancements in technology and treatment methods, including helical tomotherapy, have decreased toxicity and increased the effectiveness of adjuvant radiation therapy.

Dr. Olga Olevsky
Dr. Olga Olevsky, Oncologist and member of the Comprehensive Mesothelioma Program at UCLA, addressed recent developments in systemic therapies for pleural mesothelioma, including numerous immunotherapy treatments and treatments involving cancer stem cells. Dr. Olevsky indicated that as more systemic therapies become available, developments in identifying and correlating biomarkers may allow doctors to identify which therapy will be most effective for a given patient.

Dr. J. Andrea McCart, Associate Professor at the University of Toronto Department of Surgery, presented the results of a recent study regarding the use of virotherapy as adjuvant to debulking surgery for peritoneal mesothelioma. She also presented the results of animal studies involving the use of virotherapy in the treatment of pleural mesothelioma, concluding that the favorable results suggest that it should be developed for use in humans.

Dr. Raymond Wong
Pacific Meso Center Research Scientist Raymond Wong, PhD gave a presentation regarding the results of his study at the Pacific Meso Center Lab in Los Angeles using mesenchymal stem cells to deliver drugs to tumor cells to increase the effectiveness of immunotherapy agents. He noted the opportunity to incorporate delivery via mesenchymal stem cells with the many studies that are currently being conducted for the new PD-1 immune checkpoint blocking drugs.

Patient Resources and Advocacy

Lien Hua-Feng,
Nurse Practitioner
Lien Hua-Feng, Nurse Practitioner at the Pacific Meso Center, gave an eye-opening presentation regarding deceitful tactics employed by disreputable lawyers seizing on the vulnerability of patients diagnosed with mesothelioma. She provided examples of websites appearing to be maintained by medical professionals offering free assistance with medical treatment and contacting mesothelioma specialists. But the “disclaimer page” on the sites reveals that they are really maintained by a law firm and should not be relied upon for making medical decisions. She explained that, instead of getting reliable medical information, patients who contact the sites are besieged with calls from so-called “patient advocates” or attorneys seeking to sign them as clients. Nurse Hua-Feng warned patients of the importance of turning to “real” medical professionals for reliable medical information and experienced attorneys for reliable legal information.

Linda Reinstein, President and CEO of the Asbestos Disease Awareness Organization, gave a presentation on recent legislation regarding asbestos and the status of her ongoing efforts to get congress to enact a meaningful ban of asbestos in the United States.

“Hollywood Ending”

Clare Cameron
Pacific Meso Center Executive Director Clare Cameron gave an enlightening presentation regarding the long-standing use of asbestos in the film industry and the number of actors and production workers who have been stricken with mesothelioma. She provided shocking statistics about the amount of asbestos used in such classic movies as “Wizard of Oz,” “White Christmas” and “It’s a Wonderful Life.”

The symposium concluded with an emotional presentation from Mia Lauter, wife of actor Ed Lauter, who appeared in over 550 feature productions and lost his life to mesothelioma in 2013. She explained that when Ed was diagnosed, the only treatment options his doctor told him about were chemotherapy and amputation of his lung though EPP. Ed eventually had chemotherapy and died shortly thereafter.

Mia expressed regret over not knowing about the Pacific Meso Center at the time, and how, with information about additional treatment options such as the lung-sparing treatments available through UCLA and Dr. Cameron, Ed’s situation could have been different.

Mia and Ed Lauter
Mia is converting her grief into action to improve the outcomes of others who contract mesothelioma, both in and out of the entertainment industry. She is working with PMC to hold a fundraising gala in November at the SLS Hotel in Hollywood. Ed’s good friend and former co-star Liam Neeson has committed to participate in the event which will raise much needed funds for mesothelioma research conducted by PMC.

Mia stated that when Ed was diagnosed, he and others afflicted with mesothelioma needed a “louder voice.” Now, with her commitment to raising awareness and the need for research, mesothelioma sufferers will have a “Lauter voice!”

The Pacific Meso Center plans to release videos of the symposium presentations on its website in the coming weeks.

Friday, May 1, 2015

Fight Mesothelioma, Raise Awareness, Have Fun

This Sunday, May 3, sunny Dana Point, California will host the 9th Annual Dana Point Grand Prix (DPGP). Professional cyclists, amateurs, and kids (yes kids!) will race around downtown Dana Point in the largest single day criterion race in America!

The races will begin at 7:00 a.m. sharp and will include 13 races total, including free Youth Races sponsored by the Dana Point Community Cycling Foundation. There will also be a $12,000 Pro Women’s criterium prize, the largest in Southern California history. It’s not all about cycling of course, there will be music, food, and craft beer to be enjoyed by all, cyclist or not.

In remembrance of John Johnson and his courageous fight against Mesothelioma, the Johnson Family is sponsoring the final event of the day, the John Johnson Family Pro NCC Classic for the third year in a row.  John Johnson was a veteran and plumber who was poisoned by asbestos, contracted mesothelioma, underwent aggressive treatment to prolong his life, but ultimately succumbed to the disease. 

John Johnson Family
After his death, the Johnson family set out to increase public awareness of this horrible disease which disproportionately affects military veterans, by providing substantial funding for a mesothelioma treatment center at the West Los Angeles VA Medical Center, and by pushing for changes in the law which impacts the rights of all mesothelioma sufferers. John’s son, Michael, is a competitive cyclist who will be participating in the day’s events and is also a hard-charging advocate and source of information and support for mesothelioma patients and their families.

We would love to see you there!

All Proceeds from the DPGP Youth Races benefit the Boys & Girls Clubs of Capistrano Valley.

For registration information, details, and directions, click here.

Wednesday, April 29, 2015

Jury Finds Colgate-Palmolive Talcum Powder Causes Mesothelioma, Awards $13 Million.

Los Angeles County, CA  

A jury in Los Angeles County (Chatsworth) yesterday on April 28, 2015 unanimously found that Colgate-Palmolive’s Cashmere Bouquet talcum powder, which they sold from the 1930s to 1995, caused our client Judith Winkel’s malignant pleural mesothelioma.

The jury deliberated just two hours. They found that Colgate failed to warn consumers about their defective product, among other violations. The jury also found that Colgate, which denied that their product contained asbestos, was guilty of malice, which exposed Colgate to possible punitive damages.

On nearly a daily basis from 1961 to 1977, Judith Winkel used Cashmere Bouquet Talcum powder, primarily after showering. Like every other consumer, she loved the fragrance but had no idea the silky white powder could later cause one of the most insidious cancers known to medicine.

This was the first verdict ever against Colgate-Palmolive, whose army of lawyers argued that their product did not contain asbestos, that Judith Winkel did not use their product, that her life would not be shortened by mesothelioma, and that if she was exposed, the amount was too small to cause mesothelioma.

The jury disagreed, finding that Colgate’s Cashmere Bouquet Talcum Powder was 95% responsible for Judith Winkel’s mesothelioma. The evidence showed that Colgate purchased its talc from mines in Italy, North Carolina, and Montana, and the talc was contaminated with up to 20% asbestos fiber, including the most toxic form of asbestos (viz., amphibole).

The evidence also showed that scientists had begun detecting asbestos in talcum powder since 1942, but Colgate did not begin testing its Cashmere Bouquet for asbestos until 1971. At that time, Colgate was warned that their talcum powder contained dangerous levels of asbestos. But Colgate neither alerted the Food and Drug Administration (FDA) about the health risks, nor did they warn consumers that exposure to their product could cause cancer. 

Judith, a 73 year-old retired office clerk, mother and grandmother who has been married to husband John “Cubby” Winkel since 1964, was diagnosed with mesothelioma in early 2014. She was operated on by Dr. Robert Cameron of UCLA Medical School. Dr. Cameron noted that thoracic surgeons regularly use talcum powder in mesothelioma patients to retard the spread of the tumor, but when they do so they require that the talcum powder be certified as “asbestos free.”

“This trial was about accountability,” said John Winkel. “Colgate made a dangerous product but they refused to admit it. Judy and I are thankful that the jury was not bamboozled by their shenanigans. Now we just want to enjoy the time we have.”

The case was tried by our co-counsel, David Greenstone and Chris Panatier, of Simon Greenstone Panatier  and Bartlett (SGPB). A Colgate lawyer proudly boasted before trial that they would destroy our respective law firms, the Winkels and our experts. Their lawyer also warned us that their war chest to win this case was virtually bottomless.

“While we celebrate the first verdict ever against Colgate-Palmolive, and are thankful for the jury’s service, as well as the courageous work of our colleagues at SGBP,” said Roger Worthington of Worthington & Caron, P.C. “We are also mindful that Judy continues to live with mesothelioma. She and Cubby deserve compensation, but what they really want is to be able to play with their grandchildren and tend to their garden. With Dr. Cameron’s expert guidance, we are hopeful that Judy will be eligible for experimental therapies that will buy her many more years with her grandchildren and her flowers.”

“Dr. Cameron is an incredible physician,” said Cubby. “We are so thankful for his dedication. He’s always been there for us. This is a tough cancer with a bad prognosis but we’re thankful that Dr. Cameron and his team keep searching for a cure.”

Roger Worthington
April 29, 2015

Tuesday, April 28, 2015

It’s Not Too Late! Register Today for the 5th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma!

It’s not too late to register! Join us this weekend as some of the world’s leading mesothelioma experts and advocates highlight the most promising medical advances in mesothelioma treatment and cutting-edge new research.

The 5th International Mesothelioma Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma will be held this Saturday, May 2, 2015 in Santa Monica California  at Le Méridien Delfina hotel, from 8 a.m. to 5 p.m.

Experts will also discuss methods of surgical removal, including the shift from extra-pleural pnuemonectomy to lung-sparing procedures, as well as the findings from the Surgery for Mesothelioma After Radiation Therapy (SMART) trial.

The Symposium also provides an opportunity for physicians and nurses to earn continuing medical education (CME) credit. For more information, click here or call 1-888-996-MESO (6376).

Reserve your spot today!
For a copy of the brochure, click here.

Tuesday, April 7, 2015

UCLA’s Innovative Approach Improves Treatment Options for Patients with Mesothelioma

In the spring 2015 edition of the UCLA quarterly newsletter, Vital Signs, UCLA’s Comprehensive Mesothelioma Program presents their innovative approach to treating this complex and difficult to treat cancer.

As one of the early pioneers for the lung-sparing Pleurectomy / Decortication (PD) over the Extrapleural Pneumonectomy surgery, Dr. Robert Cameron, director of the UCLA Comprehensive Mesothelioma Program, has long believed that leaving the lung intact and removing only the pleura and visible cancer cells surrounding the lungs is most beneficial to the patients long term survival and quality of life. According to Dr. Cameron, “There is no current treatment that will eradicate every cell, but our goal is to help patients live for a long time with their disease while maximizing their quality of life.”

After surgery, patients are then treated with a form of high dose radiation called TomoTherapy, which is delivered to the cancer site with much greater precision than common radiation therapy, patients also experience fewer negative side effects as a result of the localized treatment.

The Comprehensive Mesotheloma team at UCLA has also pioneered treatments to address tumor regrowth after the initial treatment, including immunotherapy and cryoablation. Continual low-dose administration of interferon can delay the regrowth of tumors in some patients for five to ten years. If nodules resurface, cryoablation, a minimally invasive outpatient procedure which freezes the tumor cells and kills them can also be used instead of chemotherapy.

Dr. Cameron’s team wants to approach mesothelioma care similar to the approach of treating a chronic disease such as diabetes, holistically and with continuous support. Given how rare mesothelioma is, Dr. Cameron stresses patients to be treated at a specialty cancer center like UCLA with experience and ongoing research in this disease.

To schedule an appointment with Dr. Cameron at UCLA please call his office at (310) 470-8980.

Wednesday, April 1, 2015

Early Bird Special! Register Now for the 5th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma!


The 5th Annual Symposium will once again be held at the Le Méridien Delfina, on Saturday, May 2, 2015, from 8 a.m. to 5 p.m., in beautiful Santa Monica, California.

Dr. Robert Cameron, is the course organizer as well as the Director of the UCLA Mesothelioma Comprehensive Research Program.  Dr. Cameron also serves as the Chief of Thoracic Surgery at the West Los Angeles VA Medical Center and the Scientific Advisor at the Pacific Meso Center.

Dr. Cameron has over 28 years of experience with treating patients with malignant pleural mesothelioma. He is an expert in lung-sparing therapies including the pleurectomy/decortication, and a number of complementary adjuvant therapies.

The Symposium is co-hosted by UCLA and the Pacific Meso Center. Joining Dr. Cameron will be several physicians and mesothelioma advocates, including:
  • Walter Weder, MD, University of Zurich, Switzerland
  • Marc de Perrot, MD, MSc, Toronto Mesothelioma Research General Hospital
  • Shilpen Patel, MD, FACRO, University of Washington Medical Center
  • Peter V. Chen, MD, Hoag Family Cancer Institute
  • Percy Lee, MD, David Geffen School of Medicine, UCLA
  • Olga Olevsky, MD, David Geffen School of Medicine, UCLA 
  • J. Andrea McCart MD, MSc, FRCS(C), University of Toronto
  • Raymond Wong, PhD, Pacific Mesothelioma Center
  • Linda Reinstein, President/CEO and Co-Founder ADAO
The Symposium highlights the most promising medical advances in mesothelioma treatment and cutting-edge new research. Experts will also discuss methods of surgical removal, including the shift from extra-pleural pnuemonectomy to lung-sparing procedures, as well as the findings from the Surgery for Mesothelioma After Radiation Therapy (SMART) trial.


The Symposium also provides an opportunity for physicians and nurses to earn continuing medical education (CME) credit. For more information, click here or call 1-888-996-MESO (6376).

Register by April 17th to receive Early Bird pricing! To register for the symposium, click here.

For a copy of the brochure, click here.

Thursday, March 26, 2015

Meso Web-Surfers: Beware of Hidden Rocks

Dozens of websites would have you believe that they are in some official capacity associated with a doctor.
They suggest that by filling out a form, they will arrange to set up an appointment for you with a well-known and respected doctor. By so doing, they imply that they have a special if not formal relationship with that esteemed doctor and his employer, and that the famous doctor has endorsed their company. 
All of these suggestions are false. 

It's common sense that if you want to schedule an appointment with a doctor, no matter how famous he or she is, or where they practice, you simply need to call that doctor's office. 
Mesothelioma is a rare tumor and options are limited. There are regrettably only a handful of skilled surgeons, oncologists, radiologists and immunologists who hold themselves out as "experts" in treating Mesothelioma patients. Each of these doctors, whether it's Dr. David Sugarbarker, or Dr. Harvey Pass, or Dr. Robert Cameron, are I'm sure flattered to be recognized as experts.

But, to my knowledge, none of these doctors has officially sponsored or endorsed a mesothelioma marketing firm.

We suggest the following model be used in helping patients find the best medical care. List the doctor's name, specialty, experience, and contact information. 

For example:

Dr. Robert Cameron, MD
UCLA Cardiothoracic Surgeon and Surgical Oncologist, Director of the Comprehensive Mesothelioma Program at UCLA
Contact Administrator Martha Martinez at (310) 470-8980.

Dr. Robert Cameron, MD
West Los Angeles Veteran Administration Chief of Thoracic Surgeon
Contact Cardiothoracic Surgery Case Manager Almaz Tesfasilase at (310) 268-4543.

Dr. Robert Cameron, MD
Pacific Mesothelioma Center Scientific Advisor
Contact Executive Director Clare Cameron at (310) 478-4678.

Web-surfers: finding a doctor is not a fun process, time is precious and anxiety is high. Beware of marketers masquerading as medical liaisons. Don’t let them exploit your vulnerability.

Here’s a list of a few sites that purport to act as agents for scheduling appointments with Dr. Robert Cameron, the UCLA Medical Center and the West Los Angeles VA Medical Center:


Wednesday, March 25, 2015

UCLA Health Releases New Video Chronicling Treatment of Six-Year Meso Survivor Martha Munoz

Martha and Arturo Munoz
On March 23, 2015, UCLA Health released a new video which chronicles the medical treatment of Worthington & Caron, PC client Martha Munoz. Martha was 68 years old when she was diagnosed with malignant pleural mesothelioma in March 2009. Her husband Arturo states in the video that Martha’s doctors were giving her only 9 to 10 months to live.

In April 2009, Martha consulted with Dr. Robert Cameron, thoracic surgeon and director of the Comprehensive Mesothelioma Program at UCLA Medical Center. The video chronicles Martha’s treatment at UCLA, beginning with a lung-sparing pleurectomy/decortication surgery performed by Dr. Cameron in May 2009.

“Surgery is actually the most reliable treatment,” Dr. Cameron states in the video, “The goal is to remove all tumor we can see and take it off the lung and leave the lung in place." 

The video shows a striking comparison of radiology films of Martha’s right lung before and after the surgery. The “before” films show tumor encasing and compressing the lung, making it extremely difficult to breathe. The “after” films show all visible tumor gone and the lung expanding fully to the rib cage.


Following the surgery, Martha’s treatment included chemotherapy, state-of-the-art tomotherapy and novel cryoablation therapy which freezes and destroys new small tumors.

As Dr. Cameron explains, “Our idea is to treat this as a chronic disease, so what we do is use surgery to get rid of all the tumor we can see and use the other things like radiation, immunotherapy and cryoablation to keep it that way, just like we do with other chronic diseases that people can live a long time with.”

The video reports that six years after her diagnosis, Martha is now cancer free. “This is what you call a miracle,” says Arturo. While Martha states, “We are a very close family, and with God’s help and Dr. Cameron’s help, I can have a healthy longer life.”

To schedule an appointment with Dr. Cameron:

Contact his office at (310) 470-8980.

Dr. Cameron sees patients in consultation at his Los Angeles, California clinic located at:

Thoracic Surgery Associates
10780 Santa Monica Boulevard, Suite 100
Los Angeles, CA 90025-7613


Monday, February 2, 2015

Read All About It! The WLAVA Unfurls Its Meso Program for Veterans

It’s up!

The Veteran’s Administration’s website has been updated. Veterans with mesothelioma and asbestos-related lung cancer can now arm themselves with the tools they need to fight back.

Click here to learn more about the Comprehensive Mesothelioma Treatment and Research Program at the West Los Angeles VA.

This is a first. Since 1998, the WLAVA has partnered with UCLA Medical School to develop rational strategies to treat mesothelioma. Unfortunately, very few veterans outside of Los Angeles knew about the alliance, as the VA didn’t publicize the program (or fund it).

Today, thanks to the tireless efforts of the John Johnson family, as well as the perseverance of Dr. Robert Cameron, the VA has finally acknowledged the program publicly. This is a giant and long-overdue step in the right direction.

John Johnson’s story is well known. Mr. Johnson, a veteran, died from mesothelioma three years ago, almost to the day. When he died, the Johnson family vowed to help the VA build a nationwide mesothelioma program and publicize it so that other veterans could access specialized care on a timely basis.

This is a very special day. We have represented veterans with mesothelioma for over two decades. In nearly every case, family members have asked what they can do to reverse the Federal government’s apathy towards service-connected mesothelioma. They have inundated politicians and administrators with letters pleading for change. And now they have something to celebrate!

We want to thank all the veterans and their wives, sons and daughters for making their voices heard. We also want to single out Dr. Dean Norman, the Chief of Staff at the WLAVA.  Dr. Norman is faced with enormous challenges. Every year his workload gets heavier, while his budget gets lighter. Dr. Norman never made any excuses. He championed the Mesothelioma program from the git-go and has vowed to find the money to build it up.

Thanks again to all the doctors, nurses and staff at the WLAVA and UCLA who have never given up on their mesothelioma patients.

RGW
2/2/15

For more about information about lung-sparing surgery, cryoablation, immunotherapy, radiation therapy and the specialized approach to treating sarcomatoid mesothelioma offered at the WLAVA, please click here.

Friday, December 19, 2014

Son of a Mesothelioma Victim Shows Veterans with Mesothelioma How to Get the Right Answers, Right Away

LOS ANGELES, Dec. 19, 2014 /PRNewswire/ — The West Los Angeles Veterans' Administration Medical Center (West LA VAMC) has taken an important first step to help victims suffering with malignant pleural mesothelioma (MPM), by establishing a Comprehensive Mesothelioma Center at the West LA VAMC.

"Unfortunately, the center is not on the radar," said Clare Cameron, executive director of The Pacific Meso Center. "There is no mention of the Center on the VA website and many doctors in the VA system aren't clued in as to where to get advice or how to utilize the system.  In the meantime, veterans are being misdiagnosed or needlessly suffering without access to specialized care."

The Comprehensive Mesothelioma Center (CMC) in West Los Angeles is headed by Dr. Robert B. Cameron, MD, FACS. His team includes doctors and nurse practitioners who specialize in the areas of pathology, radiation, pulmonary (lung), oncology (cancer) and anesthesia. All have extensive experience with diagnosing and treating MPM, an asbestos-related cancer affecting the lining of the chest - the pleura.

The Pacific Meso Center (PMC) at the Pacific Heart Lung & Blood Institute, a 501(c)(3) non-profit research organization, focused on finding better treatments for victims of MPM, has issued a protocol to help mesothelioma sufferers navigate the system and get to the right specialists in time:

Step 1: The patient should inform his or her doctor at his local VA facility about the specialized treatment available at West LA VAMC - the only specialized mesothelioma treatment center in the VA system.

Step 2: Ask the local doctor to contact the West Los Angeles VAMC and request an "inter-facility" consult through the VA's "TeleHealth" program. The person to contact is Almaz Tesfasilase, the cardiothoracic surgery case manager at the West LA VAMC, at (310) 268-4543.

Step 3: Doctors at the CMC will conduct a "virtual consult" by reviewing the patient's medical records and films. They can then assist the local VA doctor with determining the precise diagnosis and recommending a course of treatment.

Step 4: If appropriate, the patient can be referred to the West LA VAMC for specialized treatment. A patient referred to the CMC will have travel expenses paid for by the VA. While in Los Angeles, complimentary lodging will be arranged at the Fisher House, the new West Los Angeles Hotel or a local hotel. The CMC will also arrange for transportation between the hotel and the medical center.

The PMC acknowledges the support of the John Johnson family. John Johnson was a veteran who passed away from mesothelioma in 2012. According to Michael Johnson, "My father might be alive today if he had access to specialists within the VA, but by the time he had heard about Dr. Cameron and his team from friends outside of the VA, it was too late." Johnson's 501(c)(3) non-profit, J.J. Mesothelioma Foundation | Fight Mesothelioma Now!, has a mission to reach out and help mesothelioma sufferers and their families with encouragement and advice, and guide them to the right people at the VA.  See Johnson's step by step video guide.

For further information, please contact:

Clare Cameron – 310-478-4678

Tuesday, December 9, 2014

Secretary McDonald, Here is a Win-Win, The Mesothelioma Center of Excellence.

Dear Secretary McDonald:

Here’s a win-win for you, as you emerge from the wreckage of the “death by waiting list” imbroglio.

Thanks to the courage of Dr. Dean Norman and Dr. Robert Cameron, the VA Medical Center in West Los Angeles has established a Comprehensive Mesothelioma Center.  For Navy vets exposed to asbestos while serving their country, mesothelioma is a war-related disability.  It’s estimated over 1,000 vets annually are diagnosed with this insidious cancer. But until now the VA has never built a treatment program, as it has for Agent Orange, nuclear radiation and PTSD.



The CMC is a giant and long overdue step in the right direction. Unfortunately, the VA has not publicized the program, veterans don't know about it, very few VA doctors outside of LA are aware of it, and it’s not well funded. Ironically, the problem is the lack of a waiting list.  Consequently, veterans are suffering without access to specialized care.

You can easily change this. And, for the thousands of vets now and in the future with mesothelioma who will be fighting for their life, you should. Please click here to view a video I prepared on the problem and solution. 

I have written to you and your predecessor before, without any return comment. Please respond. I am available to fly to Washington DC to meet with you in person.

Thank you for your service.

Roger G. Worthington